Mehr »
Mittwoch, 18.07.2018 Börsentäglich über 12.000 News von 586 internationalen Medien



24 h / 7 T
7 Tage



24 h / 7 T
7 Tage








Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Ad hoc-Mitteilungen
13.10.2017 | 17:46
(4 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

DUBLIN, October 13, 2017 /PRNewswire/ --

The "Biologic and Medical Imaging Reagents: Global Markets" report has been added to Research and Markets' offering.

Research and Markets Logo

The scope of the study includes the biological imaging reagents that are already commercialized or likely to be commercialized within the next five years. Fluorescent probes and dyes; imaging nanomaterials (including quantum dots and other nanoparticles); fluorescent proteins; contrast reagents for MRI, X-ray and ultrasound; and imaging radiopharmaceuticals are studied. Both the in vivo and in vitro market segments are included. Each technology is analyzed to determine its market status, impact on future market segments and forecast growth from 2017 through 2022. Technology status and market driving forces are also discussed.

Imaging reagent producers and the industry structure are examined in specialized segments of the industry. We also review industry alliances and acquisitions, and the use of biological imaging reagents in key diagnostics and research and development (R&D) tools platforms, including microarrays, lab-on-a-chip devices, DNA sequencing, PCR and cellular analysis. The markets for novel biological imaging reagent applications, including targeted multifunctional and hybrid therapeutic reagents, are analyzed, and the main companies in these fields are highlighted.

Topics Covered in this Report Include:

  • Fluorescent dyes and probes.
  • Fluorescent proteins.
  • Nanoparticles, including quantum dots.
  • Supermolecules.
  • Imaging radiopharmaceuticals.
  • Contrast reagents for X-ray/CT, MRI and ultrasound.

Topics not Covered in this Report Include:

  • Nanotechnology.
  • Drug delivery.
  • Coatings.
  • Supramolecular chemistry.
  • Imaging instruments and software.

Companies Mentioned

  • ABT Molecular Imaging Inc.
  • ABX Advanced Biochemical Compounds Gmbh
  • Active Motif Chromeon Gmbh
  • Acusphere Inc.
  • Advanced Accelerator Applications Sa
  • Advanced Proteome Therapeutics Inc.
  • Advanced Research Technologies Inc.
  • Affibody Ab
  • Agenix Ltd.
  • Alseres Pharmaceuticals Inc.
  • Alzhyme Pty Ltd.
  • Amag Pharmaceuticals Inc.
  • American Dye Source Inc.
  • American Elements
  • Anaspec Inc.
  • Anticancer Inc.
  • Aposense
  • Areva
  • Astellas Pharma Inc.
  • Astrazeneca Ltd.
  • (100+ Others)

Key Topics Covered:

1: Introduction

2: Executive Summary

3: Overview

4: Biological Imaging Technologies

5: Biological Imaging Reagents Applications

6: Biological Imaging Reagents Industry Structure

7: Competitive Landscape

8: Biological Imaging Reagents Markets

9: Patent Status

10: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/dfkrq3/biologic_and

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

© 2017 PR Newswire